A porphycene-gentamicin conjugate for enhanced photodynamic inactivation of bacteria

Ingrid Nieves, Cormac Hally, Cristiano Viappiani, Montserrat Agut, Santi Nonell

Producció científica: Article en revista indexadaArticleAvaluat per experts

27 Cites (Scopus)


A novel photoantimicrobial agent, namely 2-aminothiazolo[4,5-c]-2,7,12,17-tetrakis(methoxyethyl)porphycene (ATAZTMPo-gentamicin) conjugate, has been prepared by a click reaction between the red-light absorbing 9-isothiocyanate-2,7,12,17-tetrakis(methoxyethyl)porphycene (9-ITMPo) and the antibiotic gentamicin. The conjugate exhibits submicromolar activity in vitro against both Gram-positive and Gram-negative bacteria (Staphylococcus aureus and Escherichia coli, respectively) upon exposure to red light and is devoid of any cytotoxicity in the dark. The conjugate outperforms the two components delivered separately, which may be used to enhance the therapeutic index of gentamicin, broaden the spectrum of pathogens against which it is effective and reduce its side effects. Additionally, we report a novel straightforward synthesis of 2,7,12,17-tetrakis(methoxyethyl) porphycene (TMPo) that decreases the number of steps from nine to six.

Idioma originalAnglès
Número d’article103661
RevistaBioorganic Chemistry
Estat de la publicacióPublicada - d’abr. 2020


Navegar pels temes de recerca de 'A porphycene-gentamicin conjugate for enhanced photodynamic inactivation of bacteria'. Junts formen un fingerprint únic.

Com citar-ho